The Blavatnik National Awards were founded in 2007 with the explicit goal of celebrating the potential of scientists at the beginning of their independent careers, a stage of academic life that often lacks the large-scale recognition reserved for senior figures. Each year, the program honors advances in three broad categories: life sciences, chemical sciences, and physical sciences and engineering. From this year’s cohort of 18 finalists, three laureates were selected, each receiving an unrestricted cash prize of $250,000. That figure makes the Blavatnik National Award the largest unrestricted scientific award in the United States for early-career scientists, meaning recipients can direct the money toward whatever research priorities they deem most promising rather than toward a funder-mandated project. Nagib earned the top honor in the chemical sciences category for his work enabling the faster discovery of better and longer-lasting pharmaceuticals.

For Nagib, the recognition is rooted in a research philosophy that has guided his laboratory since he joined Ohio State in 2014. His team develops new ways to create key medicinal building blocks by harnessing two classes of highly reactive chemical species: radicals and carbenes. Radicals are molecules or fragments that carry an unpaired electron, a structural feature that makes them extraordinarily reactive and therefore historically difficult to control in the precise, predictable way that pharmaceutical synthesis demands. Carbenes, meanwhile, are neutral species in which a carbon atom holds only two bonds and a lone pair, giving them the power to insert into other chemical bonds with remarkable efficiency. Both classes of reagents can accomplish transformations that conventional two-electron chemistry struggles to achieve, but taming them has long been a central challenge of synthetic methodology.

The practical motivation behind this work is the notoriously slow pace of pharmaceutical development. On average, it takes 10 to 15 years for a new medicine to travel from initial discovery to the market, a timeline shaped by the difficulty of designing molecules that are potent, selective, stable, and manufacturable at scale. Nagib’s methods attack this bottleneck directly by helping chemists create more potent and selective medicines faster, cheaper, and more efficiently. By giving synthetic chemists reliable new tools for constructing the molecular scaffolds on which drugs are built, his laboratory aims to compress the earliest and often most exploratory stages of the drug development pipeline, where promising candidates are identified and refined before the costly phases of testing and regulatory review begin.

Accessibility is a defining theme of the Nagib group’s approach. Rather than developing techniques that require rare equipment or specialized expertise, the laboratory has pursued chemistry that any researcher could, in principle, carry out. Nagib has described his dream for these advances as chemistry so simple that anyone in the world can do it without specialized techniques or strategies, and he has framed the group’s overarching goal as the democratization of radical chemistry so that it can be used by all, even within artificial intelligence workflows. That ambition reflects a broader shift in synthetic chemistry, where the value of a method is increasingly measured not only by what it can accomplish in an expert’s hands but by how easily it can be adopted, reproduced, and automated across the global research community.

Artificial intelligence has moved from the periphery to the center of that vision. Previously selected as a Blavatnik National Awards finalist in 2024, Nagib has since refocused a substantial portion of his research program on using machine learning to design new catalysts for drug candidates. One outcome of this effort is an open-source database that allows any researcher, even one working from a smartphone, to simulate chemical reactions and learn how to use radicals selectively. The implications of such tools are considerable. According to Nagib, chemical predictions that once would have taken more than a day to complete can now be accomplished in a few seconds, a speedup that changes the practical rhythm of research planning and lets chemists explore far larger regions of chemical space before committing laboratory time and materials to a synthesis.

Despite these dramatic gains in automation and predictive power, Nagib has been careful to emphasize that technology is a complement to human creativity rather than a substitute for it. He has argued that creativity does not come from sitting alone and having a sudden eureka moment, but instead emerges from constantly discussing new ideas, thinking carefully about why they did not pan out, and then coming up with new ones together. In his telling, the most exciting science lives at the edge of the possible, and the perseverance required to make such ideas actually work is the most rewarding part of the discovery process. That collaborative, iterative ethos is visible in the way his laboratory pairs computational prediction with hands-on experimentation, using each to inform and correct the other.

The scale of the competition underscores the significance of the honor. This year, 372 young scientists were nominated for the national awards, representing 187 academic and research institutions across 43 states and the District of Columbia. Finalists are selected by an independent jury of distinguished scientists, a process designed to insulate the evaluation from institutional influence and to reward genuine scientific impact. Since their founding in 2007, the Blavatnik Awards have invested more than $20 million in over 500 scientists worldwide, building a network of laureates and finalists whose work spans disciplines from structural biology to astrophysics. Nagib is being honored on Oct. 6 at the American Museum of Natural History in New York City during the 2026 Blavatnik Awards Gala ceremony, where the winning scientists will each give a short presentation about their research to an audience of peers, patrons, and science leaders.

Looking ahead, Nagib plans to put the monetary award to work immediately within his laboratory, directing the funds toward ongoing projects, the purchase of much-needed equipment and lab instruments, and the pursuit of other new ideas that the prize money makes feasible. Unrestricted awards of this kind are especially valuable for methodological chemistry, where the most speculative projects often struggle to attract conventional grant support before their feasibility is demonstrated. For Ohio State, the laureateship marks a milestone as the university’s first Blavatnik National Award, and for Nagib it serves as a signal from the broader scientific community. As he put it, the award mainly reflects how excited the community is about the work being done at Ohio State, and being recognized in this way motivates the team to keep chasing the stars, a fitting sentiment from a chemist whose career has been built on pursuing the reactive, unruly, and transformative corners of the molecular world.

Subject of Research: Radical and carbene chemistry methods for accelerating pharmaceutical discovery

Article Title: Ohio State professor named Blavatnik National Awards laureate

Article References: Ohio State professor named Blavatnik National Awards laureate. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: David Nagib, Blavatnik National Awards, Ohio State University, radical chemistry, carbenes, medicinal chemistry, drug discovery, artificial intelligence, catalyst design, open-source database, early-career scientists, chemical synthesis